Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
Background: Although many previous studies have confirmed that perioperative blood transfusion is associated with poor outcomes after liver transplantation (LT), few studies described the influence of single-donor platelet apheresis transfusion in living donor LT (LDLT). This study aimed to assess...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2018-01-01
|
Series: | Chinese Medical Journal |
Subjects: | |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=4;spage=426;epage=434;aulast=Zheng |
_version_ | 1818534943792300032 |
---|---|
author | Wei Zheng Kang-Mei Zhao Li-Hui Luo Yang Yu Sheng-Mei Zhu |
author_facet | Wei Zheng Kang-Mei Zhao Li-Hui Luo Yang Yu Sheng-Mei Zhu |
author_sort | Wei Zheng |
collection | DOAJ |
description | Background: Although many previous studies have confirmed that perioperative blood transfusion is associated with poor outcomes after liver transplantation (LT), few studies described the influence of single-donor platelet apheresis transfusion in living donor LT (LDLT). This study aimed to assess the effect of blood products on outcomes for LDLT recipients, focusing on apheresis platelets.
Methods: This retrospective study included 126 recipients who underwent their first adult-to-adult LDLT. Twenty-four variables including consumption of blood products of 126 LDLT recipients were assessed for their link to short-term outcomes and overall survival. Kaplan-Meier survival curve and the log-rank test were used for recipient survival analysis. A multivariate Cox proportional-hazard model and a propensity score analysis were applied to adjust confounders after potential risk factors were identified by a univariate Cox analysis.
Results: Patients who received apheresis platelet transfusion had a lower 90-day cumulative survival (78.9% vs. 94.2%, P = 0.009), but had no significant difference in overall survival in the Cox model, compared with those without apheresis platelet transfusion. Units of apheresis platelet transfusion (hazard ratio [HR] = 3.103, 95% confidence interval [CI]: 1.720–5.600, P < 0.001) and preoperative platelet count (HR = 0.170, 95% CI: 0.040–0.730, P = 0.017) impacted 90-day survival independently. Multivariate Cox regression analysis also found that units of red blood cell (RBC) transfusion (HR = 1.036, 95% CI: 1.006–1.067, P = 0.018), recipient's age (HR = 1.045, 95% CI: 1.005–1.086, P = 0.025), and ABO blood group comparison (HR = 2.990, 95% CI: 1.341–6.669, P = 0.007) were independent risk factors for overall survival after LDLT.
Conclusions: This study suggested that apheresis platelets were only associated with early mortality but had no impact on overall survival in LDLT. Units of RBC, recipient's age, and ABO group comparison were independent predictors of long-term outcomes. |
first_indexed | 2024-12-11T18:18:13Z |
format | Article |
id | doaj.art-9e57f9ab3b814c6797e043c21f8400d1 |
institution | Directory Open Access Journal |
issn | 0366-6999 |
language | English |
last_indexed | 2024-12-11T18:18:13Z |
publishDate | 2018-01-01 |
publisher | Wolters Kluwer |
record_format | Article |
series | Chinese Medical Journal |
spelling | doaj.art-9e57f9ab3b814c6797e043c21f8400d12022-12-22T00:55:22ZengWolters KluwerChinese Medical Journal0366-69992018-01-01131442643410.4103/0366-6999.225049Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver TransplantationWei ZhengKang-Mei ZhaoLi-Hui LuoYang YuSheng-Mei ZhuBackground: Although many previous studies have confirmed that perioperative blood transfusion is associated with poor outcomes after liver transplantation (LT), few studies described the influence of single-donor platelet apheresis transfusion in living donor LT (LDLT). This study aimed to assess the effect of blood products on outcomes for LDLT recipients, focusing on apheresis platelets. Methods: This retrospective study included 126 recipients who underwent their first adult-to-adult LDLT. Twenty-four variables including consumption of blood products of 126 LDLT recipients were assessed for their link to short-term outcomes and overall survival. Kaplan-Meier survival curve and the log-rank test were used for recipient survival analysis. A multivariate Cox proportional-hazard model and a propensity score analysis were applied to adjust confounders after potential risk factors were identified by a univariate Cox analysis. Results: Patients who received apheresis platelet transfusion had a lower 90-day cumulative survival (78.9% vs. 94.2%, P = 0.009), but had no significant difference in overall survival in the Cox model, compared with those without apheresis platelet transfusion. Units of apheresis platelet transfusion (hazard ratio [HR] = 3.103, 95% confidence interval [CI]: 1.720–5.600, P < 0.001) and preoperative platelet count (HR = 0.170, 95% CI: 0.040–0.730, P = 0.017) impacted 90-day survival independently. Multivariate Cox regression analysis also found that units of red blood cell (RBC) transfusion (HR = 1.036, 95% CI: 1.006–1.067, P = 0.018), recipient's age (HR = 1.045, 95% CI: 1.005–1.086, P = 0.025), and ABO blood group comparison (HR = 2.990, 95% CI: 1.341–6.669, P = 0.007) were independent risk factors for overall survival after LDLT. Conclusions: This study suggested that apheresis platelets were only associated with early mortality but had no impact on overall survival in LDLT. Units of RBC, recipient's age, and ABO group comparison were independent predictors of long-term outcomes.http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=4;spage=426;epage=434;aulast=ZhengApheresis Platelets; Blood Transfusion; Living Donor Liver Transplantation; Outcome; Red Blood Cell |
spellingShingle | Wei Zheng Kang-Mei Zhao Li-Hui Luo Yang Yu Sheng-Mei Zhu Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation Chinese Medical Journal Apheresis Platelets; Blood Transfusion; Living Donor Liver Transplantation; Outcome; Red Blood Cell |
title | Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation |
title_full | Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation |
title_fullStr | Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation |
title_full_unstemmed | Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation |
title_short | Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation |
title_sort | perioperative single donor platelet apheresis and red blood cell transfusion impact on 90 day and overall survival in living donor liver transplantation |
topic | Apheresis Platelets; Blood Transfusion; Living Donor Liver Transplantation; Outcome; Red Blood Cell |
url | http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=4;spage=426;epage=434;aulast=Zheng |
work_keys_str_mv | AT weizheng perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation AT kangmeizhao perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation AT lihuiluo perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation AT yangyu perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation AT shengmeizhu perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation |